The expression analysis by qRT-PCR revealed that canine CMTM6 and CMTM4 can be expressed in canine immune cells and cancer cells, both of which are considered important PD-L1 sources in the suppression of antitumor immunity (28). The gene discussed is CD274; the disease is cancer.